Expression of Indoleamine 2,3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial
Titel:
Expression of Indoleamine 2,3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial
Auteur:
Kruger, S. Ormanns, S. Roesgen, V. Legenstein, M. Haas, M. Westphalen, C.B. Duewell, P. Schnurr, M. Kirchner, T. von Bergwelt-Baildon, M. Heinemann, V. Boeck, S.